Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design

por Premawardhana, Lakdasa D., Taylor, Peter Nicholas, Okosieme, Onyebuchi E., Adlan, Mohamed A., Obuobie, Emmanuel K., Dayan, Colin Mark
Publicado 2023

Topical steroid therapy induces pro-tolerogenic changes in Langerhans cells in human skin

por Alhadj Ali, Mohammad, Thrower, Sally L, Hanna, Stephanie J, Coulman, Sion A, Birchall, James C, Wong, F Susan, Dayan, Colin Mark, Tatovic, Danijela
Publicado 2015